DOSSIER · 13F Holders · Q3 2026Healthcare · Biological Products, (No Diagnostic Substances)
NVAX
NOVAVAX INC
279 institutions still hold NOVAVAX INC as of Q3 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 670002401·Biological Products, (No Diagnostic Substances)·279 13F holders·last filed Sep 30, 2026
AI Holders Summary · Q3 2026
279 institutions reported NVAX in Q3 2026. SHAH CAPITAL MANAGEMENT leads at 13.6% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 14
259 more holders available. Log in →